Cargando…
Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study.
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833642/ https://www.ncbi.nlm.nih.gov/pubmed/33326855 http://dx.doi.org/10.1016/j.autrev.2020.102726 |
| _version_ | 1783642111202033664 |
|---|---|
| author | Kaplanski, Gilles Bontemps, Denis Esnault, Pierre Blasco, Valery Carvelli, Julien Delarbre, David Cauchois, Raphael Forel, Jean-Marie Papazian, Laurent |
| author_facet | Kaplanski, Gilles Bontemps, Denis Esnault, Pierre Blasco, Valery Carvelli, Julien Delarbre, David Cauchois, Raphael Forel, Jean-Marie Papazian, Laurent |
| author_sort | Kaplanski, Gilles |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7833642 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78336422021-01-26 Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. Kaplanski, Gilles Bontemps, Denis Esnault, Pierre Blasco, Valery Carvelli, Julien Delarbre, David Cauchois, Raphael Forel, Jean-Marie Papazian, Laurent Autoimmun Rev Article Published by Elsevier B.V. 2021-02 2020-12-14 /pmc/articles/PMC7833642/ /pubmed/33326855 http://dx.doi.org/10.1016/j.autrev.2020.102726 Text en © 2020 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Kaplanski, Gilles Bontemps, Denis Esnault, Pierre Blasco, Valery Carvelli, Julien Delarbre, David Cauchois, Raphael Forel, Jean-Marie Papazian, Laurent Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. |
| title | Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. |
| title_full | Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. |
| title_fullStr | Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. |
| title_full_unstemmed | Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. |
| title_short | Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. |
| title_sort | combined anakinra and ruxolitinib treatment to rescue extremely ill covid-19 patients: a pilot study. |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833642/ https://www.ncbi.nlm.nih.gov/pubmed/33326855 http://dx.doi.org/10.1016/j.autrev.2020.102726 |
| work_keys_str_mv | AT kaplanskigilles combinedanakinraandruxolitinibtreatmenttorescueextremelyillcovid19patientsapilotstudy AT bontempsdenis combinedanakinraandruxolitinibtreatmenttorescueextremelyillcovid19patientsapilotstudy AT esnaultpierre combinedanakinraandruxolitinibtreatmenttorescueextremelyillcovid19patientsapilotstudy AT blascovalery combinedanakinraandruxolitinibtreatmenttorescueextremelyillcovid19patientsapilotstudy AT carvellijulien combinedanakinraandruxolitinibtreatmenttorescueextremelyillcovid19patientsapilotstudy AT delarbredavid combinedanakinraandruxolitinibtreatmenttorescueextremelyillcovid19patientsapilotstudy AT cauchoisraphael combinedanakinraandruxolitinibtreatmenttorescueextremelyillcovid19patientsapilotstudy AT foreljeanmarie combinedanakinraandruxolitinibtreatmenttorescueextremelyillcovid19patientsapilotstudy AT papazianlaurent combinedanakinraandruxolitinibtreatmenttorescueextremelyillcovid19patientsapilotstudy |